An official website of the European Union
594910-2020 - Planning
Notice View
Official language (Signed PDF)
BG
CS
DA
DE
EL
ES
EN
ET
FI
FR
GA
HR
HU
IT
LT
LV
MT
NL
PL
PT
RO
SK
SL
SV
BG
CS
DA
DE
EL
ES
EN
ET
FI
FR
GA
HR
HU
IT
LT
LV
MT
NL
PL
PT
RO
SK
SL
SV
Machine translation HTML
BG
CS
DA
DE
EL
ES
EN
ET
FI
FR
GA
HR
HU
IT
LT
LV
MT
NL
PL
PT
RO
SK
SL
SV
Notice
Official language
594910-2020 - PlanningSee the notice on TED website 
594910-2020 - PlanningUnited Kingdom-London: Vaccines for veterinary medicine
OJ S 240/2020 09/12/2020
Prior information notice
Supplies
Legal Basis:
Directive 2014/24/EU
Section I: Contracting authority
I.1.
Name and addresses
Official name: Defra Network eTendering Portal
Official name: Defra Network eTendering Portal
Postal address: 17 Nobel House
Town: London
NUTS code: UK United Kingdom
Postal code: SW1P 3JR
Country: United Kingdom
E-mail: Aman.sharma@defra.gov.uk
Telephone: +44 2072385921
Internet address(es):
I.2.
Information about joint procurement
The contract is awarded by a central purchasing body
I.3.
Communication
Additional information can be obtained from the abovementioned address
I.4.
Type of the contracting authority
Ministry or any other national or federal authority, including their regional or local subdivisions
Ministry or any other national or federal authority, including their regional or local subdivisions
I.5.
Main activity
General public services
General public services
Section II: Object
II.1.
Scope of the procurement
II.1.1.
Title
CMO — GMP Manufacturer
Reference number: 31671
II.1.2.
Main CPV code
33651690 Vaccines for veterinary medicine
33651690 Vaccines for veterinary medicine
II.1.3.
Type of contract
Supplies
Supplies
II.1.4.
Short description
APHA require a Contract Manufacturing Organisation (CMO) that is certified to EU Good Manufacturing Practice (GMP) standards to manufacture an expressed protein that will be used as an in vivo skin test to differentiate infected from Vaccinated animals (DIVA) in a food producing animal. The APHA is working towards holding a Marketing Authorisation (MA) for the in vivo skin test as an Immunological Veterinary Medicinal Product (IVMP).
II.1.5.
Estimated total value
Value excluding VAT: 2 000 000,00 GBP
Value excluding VAT: 2 000 000,00 GBP
II.1.6.
Information about lots
This contract is divided into lots: no
This contract is divided into lots: no
II.2.
Description
II.2.2.
Additional CPV code(s)
33651600 Vaccines
33651600 Vaccines
II.2.3.
Place of performance
NUTS code: UK United Kingdom
II.2.4.
Description of the procurement
APHA require a Contract Manufacturing Organisation (CMO) that is certified to EU Good Manufacturing Practice (GMP) standards to manufacture an expressed protein that will be used as an in vivo skin test to differentiate infected from Vaccinated animals (DIVA) in a food producing animal.
II.2.14.
Additional information
2000000
II.3.
Estimated date of publication of contract notice
01/12/2021
01/12/2021
Section IV: Procedure
IV.1.
Description
IV.1.8.
Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: yes
The procurement is covered by the Government Procurement Agreement: yes
Section VI: Complementary information
VI.3.
Additional information
The authority is holding a supplier engagement event on the 20 January 2021 via video conference.
If you are interested in attending please register your interest with aman.sharma@defra.gov.uk
VI.5.
Date of dispatch of this notice
04/12/2020
04/12/2020
